Abiraterone is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that reduce testosterone and has already spread to other parts of the body) as well as metastatic high-risk castration-sensitive prostate cancer.

The medicine is only available with your doctor’s prescription.

The product is available in the following dosing forms:

1. Tablet

Note – Women of childbearing potential shouldn’t use or handle abiraterone tablets without protection (for example, gloves).